Découvrez une carrière au service d’une plus grande cause

The Clinical Project Manager (CPM) is accountable for the day-to-day planning. executing, and reporting, (from first site initiation visit to and including study site close-out), of assigned Global Drug Development (DEVELOPMENT) studies in compliance with the Sponsor´s processes and regulatory requirements.

The CPM is the single point of contact and study team lead, in the country/cluster/hub, for the assigned studies. The CPM is responsible for assuring aligned communication with Trial Leads and other CTT members, locally with Clinical Research Associates (CRAs), CRA Managers and other key associates on the execution and progress of their studies. The CPM collaborates with the SSO Country Manager, SSO Country Head, SSO Feasibility Manager, SSO Study Start-up Manager and SSO Site Partnership Manager in the planning, execution, and delivery of their assigned studies. Accountable for execution and reporting of assigned DEVELOPMENT studies in E2E product line Clinical Operations Program Head/Study Lead/CPM-CRA. Can be assigned partially to participate in the review process of Site Monitoring Plans across the Portfolio.

Accountabilities

Study & Site Operations strategy.

• Supports SSO Study Start-up Manager with the development of country/cluster/hub study execution plans and timeline commitments.

• Participates with the recruitment sub-team and supports the development of innovative solutions for site and patient participation to ensure the delivery of assigned studies on time.

• Proactively identifies risks and opportunities for the assigned studies in the country/cluster/hub and develops respective mitigation plans.

Initiation and conduct of trials.

• Supports study feasibility as requested by the SSO Feasibility Manager by providing input to the study protocol and operational aspects of the study.

• Maintains a strong knowledge of the study protocol to answer standard operational questions from CRAs, sites and Country/Cluster/Hub personnel.

• Drives the conduct of the study (tracks status, maintains relevant reporting systems, oversees forecasts, progress, and mitigation plans) to ensure all study operational aspects are on track.

• Ensures recruitment targets are met and reviews enrollment at the site level including responsibility for obtaining approval from the STUDY LEADER on enrolling above site targets. Responsible to set up contingency plan to ensure recruitment targets are achieved in accordance with trial execution plan.

• Oversees local study team activities to achieve study timelines and quality execution, (proposing and implementing corrective actions where appropriate), according to the Sponsor´s standards and relevant regulations.

• Leads/chairs country/cluster/hub study team meetings, participates in global clinical trial team meetings, as required, and is the single point of contact for the conduct of assigned studies.

• Maintains oversight of country/cluster/hub level data management activities, including timely understanding of screen failure reasons and discontinuation rates, review of patient profiles, and proactively identifies data entry issues (on quality and timing) to mitigate queries, proactively identifies query resolution issues.

• Coordinates the study handover process with CRAs and their managers to ensure proper documentation and communication, when necessary

• Tracks all study close-out activities and ensures they are performed in a timely manner, in collaboration with CRAs and key study stakeholders.

Delivery of quality data and compliance to quality standards

• Conducts or coordinates training, as needed, for CRAs to support site readiness to recruit and study execution ensuring adherence to clinical data standards, prevailing legislation, GCP, Ethical Committee and SOP requirements.

• Conducts or coordinates local investigator meetings, as needed, and ensures relevant training documentation is archived in the Trial Master File

• Evaluates potential challenges/risks in the protocol and operational aspects of the study; assesses impacts, develops risk management plans, and communicates/escalates to global teams and SSO Hub Head Portfolio, as appropriate.

• Accountable for monitoring quality and issue resolution through timely review and approval of study monitoring visit reports to ensure quality trial oversight and appropriate issue escalation.

• Promotes a compliance culture advocating the adherence to highest standards and ethical integrity, always ensuring human subject protection and reliability of trial results.

• Acts as the escalation point for issues in monitoring visit reports (MVRs) for the assigned studies.

• Responsible for evaluating trends identified in MVRs and communicating/escalating these to global teams, as appropriate. Communicates with CRAs and their managers to ensure issue resolution in a timely manner.

• Provides feedback about the quality of monitoring activities to CRA Managers, MSOM, SSO Country Managers, FSP line managers, as appropriate, and to local QA (when required per the Sponsor´s SOPs)

• Supports inspection readiness and submission preparation for monitoring-related activities; assists and coordinates with country Portfolio Execution and Quality Assurance for internal audits organization and HA inspections, as required, and ensures implementation of corrective actions within specified timelines.

Budget and productivity

• Monitors the status of site budget and contract negotiations as well as the collection and review of essential documents throughout study conduct.

• Tracks study budget with appropriate study budget in responsible Country. Ensures timely TCF preparation and submission.

• Processes invoiceable items for site level clinical study activities to allow timely payments.

Activities & Interfaces

• Serves as core member of the Global Clinical Trial team as a Country and Hub representative responsible for all local level feedback to the global trial execution teams.

• Interfaces with SSU teams to ensure on-time initiation of all sites within geography.

• Interfaces with Country study execution teams, including CRAs and CRA Managers, to ensure on-time recruitment, data delivery, and study close out.

Key Performance Indicators

• Timely submission and delivery of high-quality clinical trial documentation/data.

• Performance against study commitments at the country/cluster/hub level, including delivery of studies per defined timelines (including study close out), number of patients and quality.

• Delivery of study milestones according to prevailing legislation, GCP, Ethical Committee and SOP requirements.

Please note that the selection process will not begin until the second week of January. Candidates will receive updates from then on.

IQVIA is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. We create intelligent connections to accelerate the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide. Learn more at https://jobs.iqvia.com